INT296995

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.03
First Reported 2009
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 3
Disease Relevance 3.10
Pain Relevance 0.13

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

cytosol (MLST8) cytoplasm (MLST8)
Anatomy Link Frequency
fat 1
WAT 1
MLST8 (Homo sapiens)
Pain Link Frequency Relevance Heat
agonist 48 97.20 Very High Very High Very High
Immobilon 2 63.88 Quite High
tolerance 1 49.68 Quite Low
Potency 4 21.52 Low Low
anesthesia 3 5.00 Very Low Very Low Very Low
lidocaine 2 5.00 Very Low Very Low Very Low
Central nervous system 2 5.00 Very Low Very Low Very Low
dexamethasone 2 5.00 Very Low Very Low Very Low
Peripheral nervous system 2 5.00 Very Low Very Low Very Low
behavioral therapy 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Obesity 401 100.00 Very High Very High Very High
Cancer 10 84.16 Quite High
Diabetes Mellitus 20 83.36 Quite High
Death 1 56.08 Quite High
Targeted Disruption 11 49.84 Quite Low
Impaired Glucose Tolerance 1 49.68 Quite Low
Body Weight 1 37.20 Quite Low
Thinness 1 15.68 Low Low
Liver Cancer 6 5.00 Very Low Very Low Very Low
Disease 3 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
However, the function and expression of RIP140 mRNA in human subcutaneous WAT, which comprises the main store of body fat, has to our knowledge not been reported.
Regulation (reported) of WAT in fat associated with obesity
1) Confidence 0.03 Published 2010 Journal BMC Endocr Disord Section Body Doc Link PMC2825205 Disease Relevance 1.05 Pain Relevance 0
However, the regulation of Tusc5 in WAT and its potential association with obesity phenotypes remain unclear.
Regulation (regulation) of WAT in WAT associated with obesity
2) Confidence 0.02 Published 2009 Journal PPAR Research Section Abstract Doc Link PMC2830574 Disease Relevance 1.22 Pain Relevance 0.05
Unpaired t-tests were used to test for significant differences between placebo- and pioglitizone-treated groups with respect to the change in WAT target gene transcript levels following treatment, or when comparing agonist-treated versus control HepG2 cells for PPAR isoform studies.
Regulation (change) of WAT associated with obesity and agonist
3) Confidence 0.02 Published 2009 Journal PPAR Research Section Body Doc Link PMC2830574 Disease Relevance 0.84 Pain Relevance 0.08

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox